Julie Elliott - Concepedia

Author

Julie Elliott

Also Known As

Cranston, Ross, J E Elliott, J Elliott, J. Elliott, Janocko, Laura, Julie E Elliott, Julie E. Elliott, Julie Elliot, Julie Elliott, Richardson-Harman, Nicola

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles Black AIDS Institute University of Southern California University of Pittsburgh Magee-Womens Research Institute

About

Julie Elliott is an author at University of California, Los Angeles specializing in medicine, immunology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	26	3K
2	Allergy	4	4	116
3	Engineering	2	2	70
4	Public Health	2	2	840
5	Social Sciences	1	1	135

Julie Elliott

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study Victoria Hall, Sarah Foulkes, Ayoub Saei, The Lancet VaccinationPreventive MedicineVaccine DevelopmentCovid-19 Vaccine CoverageVaccine Surveillance	2021	829
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) Victoria Hall, Sarah Foulkes, André Charlett, The Lancet Long CovidSars-cov-2 Infection RatesCovid-19 PandemicInfection ControlAntibody-negative Health-care Workers	2021	732
Dysregulation of the hypothalamic‐pituitary‐adrenal (HPA) axis in irritable bowel syndrome Lin Chang, S Sundaresh, Julie Elliott, Neurogastroenterology & Motility NeuroendocrinologyGastroenterologyHypothalamic CircuitsIrritable Bowel SyndromeInflammation	2008	248
Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue Peter A. Anton, Julie Elliott, Michael A. Poles, AIDS	2000	176
A Preponderance of CCR5<sup>+</sup>CXCR4<sup>+</sup>Mononuclear Cells Enhances Gastrointestinal Mucosal Susceptibility to Human Immunodeficiency Virus Type 1 Infection Michael A. Poles, Julie Elliott, Philip Taing, Journal of Virology	2001	164
RMP-02/MTN-006: A Phase 1 Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Tenofovir 1% Gel Compared with Oral Tenofovir Disoproxil Fumarate Peter A. Anton, Ross Cranston, Angela D. M. Kashuba, AIDS Research and Human Retroviruses Pharmaceutical ScienceTenofovir 1GynecologyPlacebo GelPharmacotherapy	2012	135
Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides Patricia Fletcher, Julie Elliott, Jean‐Charles Grivel, AIDS	2006	130
Lack of Decay of HIV-1 in Gut-Associated Lymphoid Tissue Reservoirs in Maximally Suppressed Individuals Michael A. Poles, W. John Boscardin, Julie Elliott, JAIDS Journal of Acquired Immune Deficiency Syndromes	2006	117
Binding and Transfer of Human Immunodeficiency Virus by DC-SIGN<sup>+</sup>Cells in Human Rectal Mucosa Kevin B. Gurney, Julie Elliott, Hoorig Nassanian, Journal of Virology Viral ReplicationHuman Rectal MucosaImmunodeficienciesImmunologyHuman Immunodeficiency Virus	2005	116
Acyclovir Is Activated into a HIV-1 Reverse Transcriptase Inhibitor in Herpesvirus-Infected Human Tissues Andrea Lisco, Christophe Vanpouille, Egor P. Tchesnokov, Cell Host & Microbe MedicineHuman RetrovirusImmunologyAntiviral ResponseAntiviral Drug Development	2008	115

Page 1